The Charcot Lecture | beating MS: a story of B cells, with twists and turns
about
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.A Journey in Science: The Privilege of Exploring the Brain and the Immune System.Onset of secondary progressive MS after long-term rituximab therapy - a case report.Multiple sclerosis: experimental models and reality.Ocrelizumab: a B-cell depleting therapy for multiple sclerosis.The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.Neurodegeneration in multiple sclerosis and neuromyelitis optica.Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.Nano- and micro-based systems for immunotolerance induction in multiple sclerosis.Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis.Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis.The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".B Cell Therapy for Multiple Sclerosis: Entering an Era.Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis.T Cell-Transfer Experimental Autoimmune Encephalomyelitis: Pillar of Multiple Sclerosis and Autoimmunity.B cells in multiple sclerosis.Multiple sclerosis: Serum-derived exosomes express myelin proteins.Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-Commentary.No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
P2860
Q35848490-756A0E82-B5E8-4C05-B471-4AA87855BCEBQ37217037-65CA5006-6D85-40C0-B04D-2FDCC4100369Q37572960-EE58E094-A057-4249-B473-AE53A5220264Q37596784-3086093B-7C20-4CF5-BD65-9F939822E4DCQ38665518-1749DF07-1F5A-4307-83F0-BA6500C7273CQ38926183-A2EA7627-F756-43BA-BE99-A8476ABA3D07Q38934748-A523748E-EA07-409D-BBF7-39A78A31108BQ38965274-BEE10EC1-BC95-4AF3-BAFD-167465EE3D08Q39269762-641AD824-2B46-4EB2-84E3-E196CC482098Q40786516-BB5F134C-FD8F-43C9-9B93-FA48FD5130E2Q41170163-70AD12FA-F459-4049-9E43-764194D77F9CQ42330142-F43025F4-DF9B-4043-A568-0D81CFD1D6FFQ42371905-F380BB5F-E5D2-4892-908E-E5F18CF74010Q46159575-C452E37C-5D62-49CC-A22B-AADD73D26E26Q46181413-A8A93946-FC80-4AFA-B650-542F477126B9Q46583404-45479DB9-82EF-424E-9A2D-41DC6E66E72EQ47198260-CE16DAB5-C660-4ECA-9B82-A447F62B89A8Q48268219-1520AEC9-39B1-4402-9D78-B35851C4C3ABQ48321634-78F9FF2A-B40B-440B-9CE0-0455032EE654Q48568232-6CF069D4-9A7F-4931-A49C-4F2086D15832Q50800626-C94FB262-A9EA-42BE-B6F0-A5AFC2E21F5FQ52641471-CF1DFC9C-5B72-434E-827D-C20CC398EF09Q52699607-7C378BA1-4CE7-4BB6-BFAC-FF4C0DDBD696Q58697770-E7C8BE61-9FFE-4D79-B268-6EC7B5BA423A
P2860
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
@ast
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
@en
type
label
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
@ast
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
@en
prefLabel
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
@ast
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
@en
P2860
P356
P1476
The Charcot Lecture | beating MS: a story of B cells, with twists and turns
@en
P2093
Stephen L Hauser
P2860
P356
10.1177/1352458514561911
P577
2014-12-05T00:00:00Z